Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Breast Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 2Cyclophosphamide 2siltuximab 1ibrutinib 1ibritumomab tiuxetan 1Topotecan 1Rituximab 1Ribavirin 1Positron Emission Tomography Computed Tomography 1Pneumococcal Vaccines 1Pemetrexed 1NVP-BKM120 1Ketoconazole 1Inhalation 1Immunohistochemistry 1Immunoenzyme Techniques 1Imiquimod 1Granulocyte Colony-Stimulating Factor 1Gadolinium DTPA 1Filgrastim 1Etoposide 1Cryotherapy 1CF regimen 1Busulfan 1Biopsy 123-valent pneumococcal capsular polysaccharide vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, Follicular × NVP-BKM120 × Clear all
NCT01719250 2018-10-09

Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Mayo Clinic

Phase EARLY_PHASE1 Completed
7 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡